S 876 Filed
Underlined text would be added to current law. Struck-through text would be removed.
Florida Senate - 2025 SB 876
By Senator Berman
26-01316-25 2025876__
1 A bill to be entitled
2 An act relating to chimeric antigen receptor T-cell
3 therapy; creating ss. 627.64198, 627.6614, and
4 641.31078, F.S.; prohibiting health insurers and
5 health maintenance organizations issuing, delivering,
6 or renewing certain policies or contracts from
7 refusing to contract with or denying coverage for
8 certain providers of chimeric antigen receptor T-cell
9 therapy; providing an effective date.
10
11 Be It Enacted by the Legislature of the State of Florida:
12
13 Section 1. Section 627.64198, Florida Statutes, is created
14 to read:
15 627.64198 CAR-T therapy providers.—A health insurer
16 issuing, delivering, or renewing a health insurance policy in
17 this state on or after January 1, 2026, which provides coverage
18 for chimeric antigen receptor T-cell (CAR-T) therapy may not
19 refuse to contract with or deny coverage for the administration
20 of CAR-T therapy by any provider that qualifies as a certified
21 health care facility under the Food and Drug Administration
22 procedure for the CAR-T product license and that is included in
23 the policy’s provider network for any other service.
24 Section 2. Section 627.6614, Florida Statutes, is created
25 to read:
26 627.6614 CAR-T therapy providers.—A health insurer issuing,
27 delivering, or renewing a group health insurance policy in this
28 state on or after January 1, 2026, which provides coverage for
29 chimeric antigen receptor T-cell (CAR-T) therapy may not refuse
30 to contract with or deny coverage for the administration of CAR
31 T therapy by any provider that qualifies as a certified health
32 care facility under the Food and Drug Administration procedure
33 for the CAR-T product license and that is included in the
34 policy’s provider network for any other service.
35 Section 3. Section 641.31078, Florida Statutes, is created
36 to read:
37 641.31078 CAR-T therapy providers.—A health maintenance
38 organization issuing, delivering, or renewing a health
39 maintenance contract in this state on or after January 1, 2026,
40 which provides coverage for chimeric antigen receptor T-cell
41 (CAR-T) therapy may not refuse to contract with or deny coverage
42 for the administration of CAR-T therapy by any provider that
43 qualifies as a certified health care facility under the Food and
44 Drug Administration procedure for the CAR-T product license and
45 that is included in the policy’s provider network for any other
46 service.
47 Section 4. This act shall take effect January 1, 2026.
Official text from the Florida Legislature. Formatting has been adapted for reading on Ratifi.